LSM3 is a core component of the U6-associated LSM2-8 complex, which plays essential roles in pre-mRNA splicing and mRNA degradation. As part of the U4/U6-U5 tri-snRNP complex and precatalytic spliceosome, LSM3 participates in spliceosome assembly and the catalytic steps of splicing 1. The heptameric LSM2-8 complex, of which LSM3 is a member, binds specifically to the 3'-terminal U-tract of U6 snRNA and facilitates U4/U6 duplex formation, critical for snRNP biogenesis 2. LSM3 also functions in circadian rhythm regulation; downregulation of LSM3 expression in human cells lengthens the circadian period, suggesting a regulatory role in fine-tuning specific signaling pathways beyond constitutive splicing 3. Clinical relevance of LSM3 dysfunction extends to multiple disease contexts. A genome-wide association study of cardiac aging identified LSM3 as a locus linked to cardiomyopathy, with cardiac age acceleration heritable and predictive of earlier onset of arrhythmia, heart failure, and myocardial infarction 4. In prostate cancer, LSM3 is essential for cell proliferation and cell cycle progression and serves as a component of a six-gene splicing factor classifier (BCAS1, LSM3, DHX16, NOVA2, RBM47, SNRPN) with strong prognostic value 5. LSM3 expression is also associated with metastatic phenotypes in cervical cancer, correlating with progression-free survival and clustered with genes involved in rapid proliferation and invasiveness 6.